Technology

Microfluidic systems for advanced biomolecular constructs.

Precision flow control, automated synthesis, rapid mixing, and in-line measurement provide the process environment required to build and formulate complex biomolecules.

Technical foundations

Microfluidic architecture connects reagent delivery, reaction control, nanoparticle formation, measurement, and downstream processing.

Controlled self-assembly

Microfluidic formulation

Lipid nanoparticles form when lipid and aqueous streams meet under controlled conditions. Flow stability, phase ratio, mixer geometry, composition, and quench timing influence particle formation and reproducibility.

  • Defined phase ratios
  • Controlled mixing conditions
  • Quench and dilution
Payload–biology interface

Molecular delivery

Delivery performance emerges from the relationship between payload, particle composition, surface chemistry, biological environment, and route of administration.

  • Payload compatibility
  • Surface architecture
  • Release and biological interaction
Integrated engineering

Process architecture

A complete process links fluid handling, sensing, automation, purification, analytics, and material transfer into an environment that can be understood and reproduced.

  • Pressure and flow control
  • Process data and analytics
  • Downstream integration
Molecular construction

Automated synthesis

Solid-phase synthesis converts a molecular sequence into a repeatable fluidic programme. Reagent routing, contact time, washing, pressure, and in-line measurement determine how consistently each reaction cycle is executed.

  • Reagent and solvent routing
  • Timed reaction cycles
  • In-line process measurement
Lipid nanoparticle formulation

Controlled mixing turns two liquid phases into a delivery system.

Nanoparticle formation occurs rapidly. The equipment surrounding the mixer exists to define the conditions under which that self-assembly takes place and to stabilise the product immediately afterwards.

01

Lipid phase

Lipid components are prepared in an organic solvent, commonly ethanol.

02

Aqueous phase

The biomolecular payload is prepared in a compatible aqueous buffer.

03

Rapid mixing

Defined streams meet in a mixer; the solvent shift drives lipid self-assembly around the payload.

04

Quench and dilution

Controlled dilution limits further particle growth and reduces the solvent concentration.

05

Downstream processing

Buffer exchange, concentration, filtration, and analytical control prepare the formulation for its next stage.

Critical process variables
Phase composition
Flow-rate ratio
Total flow and mixing energy
Time to quench
Automated oligonucleotide synthesis

A chemical sequence executed as a controlled fluidic cycle.

In solid-phase synthesis, bases are added sequentially to a growing chain immobilised on a support. Each addition requires the same core operations to be delivered in the correct order and under defined conditions.

01

Detritylation

A protecting group is removed to expose the reactive site for the next base addition.

02

Coupling

The next phosphoramidite is delivered to the solid support and coupled to the growing sequence.

03

Oxidation or thiolation

The newly formed linkage is converted into its stable phosphate or phosphorothioate form.

04

Capping and wash

Unreacted chains are capped and the flow path is washed before the cycle repeats.

Repeatable synthesis therefore depends on accurate metering, chemically compatible flow paths, controlled contact times, effective washing, and measurement capable of showing whether each cycle is performing as intended.

Scientific context

See how process conditions connect to delivery behaviour.

View research